PRESS RELEASE published on 12/20/2023 at 12:45, 10 months 19 days ago MindBio Therapeutics CEO Provides End of Year Video Update on Phase 2 Clinical Trials
PRESS RELEASE published on 11/21/2023 at 14:42, 11 months 17 days ago MindBio Therapeutics Team Members Honoured with Industry Leading Awards
PRESS RELEASE published on 10/31/2023 at 07:30, 1 year ago MindBio Therapeutics CEO Presents World First Phase 2B Take-Home Microdosing Clinical Trial in Cancer Patients
PRESS RELEASE published on 10/29/2023 at 03:00, 1 year ago MindBio Therapeutics Begins Dosing MB22001 in World First Phase 2B Microdosing Clinical Trial In Advanced Stage Cancer Patients
PRESS RELEASE published on 10/26/2023 at 14:50, 1 year ago Mindbio Therapeutics Nominated for Company of the Year in Industry Awards
PRESS RELEASE published on 10/24/2023 at 13:25, 1 year ago MindBio Therapeutics CEO Provides Video Update on Phase 2a Depression Trial Using MB22001
PRESS RELEASE published on 10/05/2023 at 11:29, 1 year 1 month ago Tenth Patient With Depression Starts Dosing MB22001 in Take Home Microdosing Trials
PRESS RELEASE published on 09/14/2023 at 15:45, 1 year 1 month ago Mindbio Therapeutics CEO Provides Update on Depression Trial & Novel Discoveries in Psychedelics Research
PRESS RELEASE published on 09/05/2023 at 11:50, 1 year 2 months ago MindBio Therapeutics Announces Major Genetic Discovery in Microdosing Research
PRESS RELEASE published on 08/24/2023 at 08:30, 1 year 2 months ago Begins Dosing Mb22001 in Phase 2 Clinical Trial in World First Take-Home Microdosing Study in Patients with Depression
Published on 11/08/2024 at 14:00, 46 minutes ago NOA Lithium Closes $912,596 1st Tranche of the $2.7 Million Non-Brokered Private Placement
Published on 11/08/2024 at 14:00, 46 minutes ago Ballpoint Marketing - Leader in Handwritten Mail - Acquires a Friendly Competitor: Robot Ink Marketing
Published on 11/08/2024 at 13:30, 1 hour 16 minutes ago Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
Published on 11/08/2024 at 13:05, 1 hour 41 minutes ago Aton Announces Corporate and Operations Update
Published on 11/08/2024 at 13:00, 1 hour 46 minutes ago Honey Badger Announces Change of Transfer Agent
Published on 11/08/2024 at 12:31, 2 hours 15 minutes ago Original-Research: ORBIS SE (von GSC Research GmbH): Kaufen
Published on 11/08/2024 at 12:25, 2 hours 21 minutes ago freenet Executive Board formulates financial ambition until 2028 - EBITDA and free cash flow to grow significantly
Published on 11/08/2024 at 12:11, 2 hours 35 minutes ago PNE AG selected by the European Commission for funding a project to produce hydrogen
Published on 11/08/2024 at 12:32, 2 hours 14 minutes ago Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:32, 2 hours 14 minutes ago Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 2 hours 31 minutes ago Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 2 hours 31 minutes ago Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 08:00, 6 hours 46 minutes ago DAMARTEX / Droits de vote bruts et réels 31 octobre 2024
